PPARGC1A and type 2 diabetes mellitus: Zhang et al[30] found that the polymorphisms of Thr394Thr (rs2970847) and Gly482Ser (rs8192678) in the PPARGC1A gene were associated with the therapeutic efficacy of multiple-dose rosiglitazone in Chinese patients with T2DM.